金黄色葡萄球菌与铜绿假单胞菌在抗菌药物暴露期间的协作
本研究通过时间-杀菌实验,评估左氧氟沙星、庆大霉素、克林霉素、万古霉素和多粘菌素B对铜绿假单胞菌PA01与两种金黄色葡萄球菌表型(正常表型MRSA COL和小菌落变异型MRSA Ia48)共培养的杀菌效果。结果显示,铜绿假单胞菌削弱了克林霉素对正常表型MRSA的杀菌活性,Emax从单培养的3.67降至共培养的1.86;庆大霉素暴露下铜绿假单胞菌始终占优势,而左氧氟沙星浓度≥1.5 mg/L时小菌落变异型MRSA可在联合群体中占优。
要点
- 铜绿假单胞菌可降低克林霉素对正常表型MRSA的杀菌效果。
- 庆大霉素暴露下铜绿假单胞菌在共培养中占主导地位。
- 左氧氟沙星≥1.5 mg/L时小菌落变异型MRSA可主导联合群体。
核心结论
- 铜绿假单胞菌的存在削弱了克林霉素抗金黄色葡萄球菌的活性。
研究设计与样本
- 采用时间-杀菌实验,针对铜绿假单胞菌PA01分别与正常表型MRSA COL或小菌落变异型MRSA Ia48的共培养。
主要发现
- 克林霉素对正常表型MRSA的最大杀菌Emax从单培养的3.67(95%CI 2.79-4.56)降至共培养的1.86(95%CI 1.35-2.37)。
- 机制模型显示克林霉素对敏感正常表型MRSA亚群的最大杀菌速率常数在单培养为0.267 h-1,共培养为0.0395 h-1。
- 庆大霉素暴露下,无论药物浓度或金黄色葡萄球菌表型,铜绿假单胞菌均为共培养中的优势菌。
- 左氧氟沙星浓度≥1.5 mg/L时,小菌落变异型MRSA可在联合群体中占主导。
- 其他抗菌药物未观察到显著保护效应。
临床怎么用
- 在混合感染中,若铜绿假单胞菌与金黄色葡萄球菌共存,克林霉素的抗葡萄球菌效果可能降低。
- 庆大霉素暴露时铜绿假单胞菌可能占优,需考虑覆盖铜绿假单胞菌。
- 左氧氟沙星浓度≥1.5 mg/L时需警惕小菌落变异型MRSA的选出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The optimal selection of antibacterials during polymicrobial infections is poorly defined. The objective of the current investigation was to quantify the pharmacodynamics of relevant antimicrobials during co-culture of Pseudomonas aeruginosa with two separate Staphylococcus aureus phenotypes. METHODS: Time-kill experiments were conducted against co-cultures of the P. aeruginosa strain PA01 paired with either the normal phenotype (NP) MRSA isolate COL or the small colony variant phenotype (SCVP) MRSA isolate Ia48. The killing by levofloxacin, gentamicin, clindamycin, vancomycin and polymyxin B was evaluated to investigate drugs with activity against one or both pathogens. A Hill-type function and a mechanism-based model were used to describe bacterial killing. RESULTS: P. aeruginosa attenuated the activity of clindamycin against NP MRSA, with a reduction in the Emax (maximal killing) from 3.67 (95% CI 2.79-4.56) in monoculture to 1.86 (95% CI 1.35-2.37) during co-culture, whereas a significant protective effect was not observed for other antibacterials. The reduction in NP MRSA killing by clindamycin was described well by a mechanism-based model that generated a maximal killing rate constant of clindamycin against the susceptible NP MRSA subpopulation of 0.267 h-1 in monoculture and 0.0395 h-1 in the presence of P. aeruginosa. During exposure to gentamicin, P. aeruginosa was the dominant organism in co-culture experiments regardless of the drug concentration or S. aureus phenotype; however, the SCVP MRSA was able to dominate the joint population beginning at a levofloxacin concentration of 1.5 mg/L. CONCLUSIONS: The anti-staphylococcal activity of clindamycin was attenuated by the presence of P. aeruginosa.
引用
- Lenhard JR, Smith NM, Quach CD, et al. Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure. J Antimicrob Chemother. 2019. PMID: 31219553. doi:10.1093/jac/dkz247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。